Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/27888

TDMS Study 20114-02 Pathology Tables

NTP  EXP/TEST: 20114-02                         SODIUM DICHROMATE DIHYDRATE (VI)                                  PAGE: 1
TEST TYPE: SUBCHRON 90-DAY                      INITIAL AND CURRENT BODY WEIGHT                                   DATE: 05/14/03
ROUTE: DOSED WATER                                                                                                TIME: 14:43:48

                                                         EIS REPORT 03


       FACILITY:  Southern Research Institute

       NTP C#:  C20114

       CONTRACT NUMBER:  N01-ES-15463

       CAS NUMBER:  7789-12-0

       ANIMAL SUPPLIER:  TACONIC FARMS

       CAGE RANGE:  ALL

       DATE RANGE: ALL

       REASONS FOR REMOVAL:    ALL

       REMOVAL DATE RANGE:     ALL

       TREATMENT GROUPS:       INCLUDE ALL

NTP  EXP/TEST: 20114-02                         SODIUM DICHROMATE DIHYDRATE (VI)                                  PAGE: 2
TEST TYPE: SUBCHRON 90-DAY                      INITIAL AND CURRENT BODY WEIGHT                                   DATE: 05/14/03
ROUTE: DOSED WATER                                          EISRPT03                                              TIME: 14:43:48
----------------------------------------------------------------------------------------------------------------------------------
 SPECIES-STRAIN: B6C3F1-MICE                SEX: FEMALE      WEEK ON DOSE: 14     FIRST DOSE: 11/14/01
----------------------------------------------------------------------------------------------------------------------------------
                     -----INITIAL-----         ------------CURRENT-------------       -----CHANGE------
TREATMENT            N   MEAN(G)    SD         N   MEAN(G)    SD    % REL CNTRL       N   MEAN(G)    SD

 0       MG/L       10     17.9    1.4        10     27.7    2.1                     10      9.8    2.6

 62.5    MG/L       10     18.7    0.9        10     28.0    2.7       101.0         10      9.3    2.3

 125     MG/L       10     18.7    1.1        10     25.5    1.9        92.0         10      6.8    1.2

 250     MG/L       10     18.3    1.2        10     25.5    1.7        92.0         10      7.3    1.4

 500     MG/L       10     18.1    1.1        10     24.8    1.0        89.5         10      6.7    1.1

 1000    MG/L       10     18.8    1.1        10     24.1    1.3        87.0         10      5.3    1.1




----------------------------------------------------------------------------------------------------------------------------------
 SPECIES-STRAIN: B6C3F1-MICE                SEX: MALE        WEEK ON DOSE: 14     FIRST DOSE: 11/13/01
----------------------------------------------------------------------------------------------------------------------------------
                     -----INITIAL-----         ------------CURRENT-------------       -----CHANGE------
TREATMENT            N   MEAN(G)    SD         N   MEAN(G)    SD    % REL CNTRL       N   MEAN(G)    SD

 0       MG/L       10     20.4    1.3        10     37.9    3.5                     10     17.5    2.9

 62.5    MG/L       10     21.3    1.2        10     35.6    2.7        93.9         10     14.3    2.3

 125     MG/L       10     21.6    0.8        10     34.2    3.9        90.2         10     12.6    3.6

 250     MG/L       10     21.1    1.8        10     32.6    2.1        86.0         10     11.5    2.2

 500     MG/L       10     20.7    1.7        10     30.5    2.9        80.4         10      9.8    2.5

 1000    MG/L       10     21.4    1.3        10     30.5    1.8        80.4         10      9.1    1.5

                                               -----------------------------------
                                               ---------- END-OF-REPORT ----------
                                               -----------------------------------